Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
06/2003
06/19/2003US20030114454 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
06/19/2003US20030114423 Arylamines as inhibitors of chemokine binding to US28
06/19/2003US20030114420 Anticancer agents, autoimmunine diseases, congestive heart failure, skin disorders, antiinflammatory agents
06/19/2003US20030113278 Treatment of excessive radiation (e.g. sunburn) exposure
06/19/2003US20030110577 Novel p-aminophenols and colorants containing said compounds
06/19/2003CA2470114A1 Crystalline [r-(r*,r*)]-2-(4-fluorophenyl)-.beta.,.delta.-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-heptanoic acid calcium salt (2:1)
06/18/2003EP1319000A1 1-azabicyclo 2.2.2]octan-3-one derivatives and maleimide derivatives and their use for treating cancer tumors
06/18/2003EP1318988A2 Ligands for monoamine receptors and transporters, and methods of use thereof (neurotransmission)
06/18/2003EP1318978A2 N-acylsulfonamide apoptosis promoters
06/18/2003EP1318976A2 Substituted aminopropoxyaryl derivatives useful as agonists for lxr
06/18/2003EP1318974A2 Resorcinol derivatives
06/18/2003EP1261584A4 Crystalline forms of antibiotic side chain intermediates
06/18/2003EP1140829A4 Contrast media for angiography
06/18/2003CN1425002A Pyrrolidine and piperidine derivatives and their use for treatment of neurodegenerative disorders
06/18/2003CN1111522C Technology for recovery of N-methyepyrrolidone from treatment of lithium cell industrial waste gas
06/17/2003US6579987 Diaryl-enynes
06/17/2003US6579971 Method of producing 3,4-dehydroprolines and 3,4-dehydropiperidines
06/17/2003US6579900 Can be used to reduce pain, reducing nausea in an individual undergoing chemotherapy, suppressing appetite, reducing intraocular pressure, and suppressing the immune system in an individual with an organ transplant.
06/17/2003US6579872 Bezamide derivatives for the treatment of diseases mediated by cytokines
06/17/2003US6579823 Group 8-10 metal complex comprising a bidentate or variable denticity ligand; polymerization of olefins
06/17/2003US6579328 Preparation from a sterically hindered nitroxy compound and a diazonium salt of an aromatic amine in the presence of a transition metal catalyst
06/17/2003CA2046654C Radiolabeled proteins for diagnostic or therapeutic use
06/17/2003CA2040606C Chiral catalysts for reduction of ketones and process for their preparation
06/12/2003WO2003048150A1 Substituted 5-membered n-heterocyclic compounds and their uses for treating or preventing neurodegenerative diseases
06/12/2003WO2003048121A1 Therapeutic benzamide derivatives
06/12/2003WO2003048106A2 1,3-diarylprop-2-en-1-ones, compositions containing same and use thereof
06/12/2003WO2003047575A1 Therapeutic benzamide derivatives
06/12/2003WO2003047569A1 Compositions and methods for inhibiting prenyltransferases
06/12/2003WO2003047568A1 N-aryl-n'-arylcycloalkyl-urea derivatives as mch antagonists for the treatment of obesity
06/12/2003WO2003047513A2 Method for treating ocular hypertension
06/12/2003WO2003047417A2 Ep4 receptor agonist, compositions and methods thereof
06/12/2003WO2003016273A3 Peptide arginals and methods for treating disseminated intravascular coagulation
06/12/2003WO2002017712A3 Disubstituted benzenes as insecticides
06/12/2003US20030109718 Enantioselective transformation of alpha, beta-unsaturated aldehydes using chiral organic catalysts
06/12/2003US20030109706 Serine pretease inhibitors
06/12/2003US20030109705 Novel cyanoenamines useful as ligands for modulating gene expression in plants or animals
06/12/2003US20030109666 Thermosetting resin compositions containing maleimide and/or vinyl compounds
06/12/2003US20030109569 Amorphous, pharmaceutically acceptable atorvastatin salts, especially the calcium salt, are prepared from atorvastatin lactone or from a compound of formula (I) mixture of amorphous and crystalline forms of the atorvastatin salt. HMG-CoA
06/12/2003US20030109559 N-(3-amino-2-hydroxy-propyl)substituted alkylamide compounds
06/12/2003US20030109556 Melanocortin receptor ligands
06/12/2003US20030109528 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
06/12/2003US20030109527 Novel hydroxy diphenylurea sulfonamides, compositions and intermediates thereof. The hydroxy
06/12/2003US20030109524 Benzocycloalkylenylamine derivatives as muscarinic receptor antagonists
06/12/2003US20030109517 Azacycloalkanone serine protease inhibitors
06/12/2003CA2469193A1 1,3-diarylprop-2-en-1-ones, compositions containing same and use thereof
06/12/2003CA2468967A1 N-aryl-n'-arylcycloalkyl-urea derivatives as mch antagonists for the treatment of obesity
06/12/2003CA2466757A1 Method for treating ocular hypertension
06/12/2003CA2466751A1 Ep4 receptor agonist, compositions and methods thereof
06/11/2003EP1317490A1 Catalysts containing per-ortho aryl substituted aryl or heteroaryl substituted nitrogen donors
06/11/2003EP1317456A2 Cyclic and acyclic amidines and pharmaceutical compositions containing them for use as progesterone receptor binding agents
06/11/2003EP1317429A1 Amidine inhibitors of serine proteases
06/11/2003EP1317428A1 Pyrrolidine-2-carboxylic acid hydrazide derivatives for use as metalloprotease inhibitors
06/11/2003EP1317424A2 Polyamine analogues as therapeutic and diagnostic agents
06/11/2003EP1317411A1 Derivatives of naphthalene with comt inhibiting activity
06/11/2003EP0779894B1 Electrophilic polyethylene oxides for the modification of polysaccharides, polypeptides (proteins) and surfaces
06/11/2003CN1423635A Nitrogenous compounds and antiviral drugs containing the same
06/11/2003CN1423634A Polymorphic form of atorvastain calcium
06/11/2003CN1423627A 维生素d类似物 Vitamin d analogues
06/11/2003CN1422851A Substituted penta azacylo compounds and their use for preventing and treating nervous retrogression disease
06/11/2003CN1422846A Pyrrole derivative preparation method
06/10/2003US6576783 Oligonucleotide protecting groups
06/10/2003US6576657 Amidino derivatives and their use as thrombin inhibitors
06/10/2003US6576642 Inhibitors of the production of Ig E antibodies, antiallergens
06/10/2003US6576612 Intravenous administration of an alpha halogen acryloyl distamycin derivative
06/10/2003US6576159 Colorants, electroconductive materials; solubility, dissociation
06/10/2003CA2057273C Alkenyl succinimides as luboil additives
06/05/2003WO2003046200A2 Methods for ligand discovery
06/05/2003WO2003045977A2 Peptidomimetic Inhibitors of Post-Proline Cleaving Enzymes
06/05/2003WO2003045957A1 3-biphenyl-substituted-3-substituted-4-ketolactam and ketolactone and their utilization as pesticide
06/05/2003WO2003045921A1 Heterocyclic amide compounds as apolipoprotein b inhibitors
06/05/2003WO2003045913A1 Benzamide derivatives, processes for their preparation, and their pharmaceutical use
06/05/2003WO2003045912A1 Inhibitors of factor xa and other serine proteases involved in the coagulation cascade
06/05/2003WO2003045903A1 Hydroxyethylene compounds with asp2 inhibitory activity
06/05/2003WO2002048137A3 Substituted heterocyclic phthalic acid diamide arthropodicides
06/05/2003WO2002048124A3 Piperazine derivatives
06/05/2003US20030105338 Method for processing pyrollidone and n-vinyl pyrollidone residues
06/05/2003US20030105337 Method for producing maleimides
06/05/2003US20030105279 Aromatic and heteroaromatic acid halides for synthesizing polyamides
06/05/2003US20030105153 Substituted cyclic amine metalloprotease inhibitors
06/05/2003US20030105138 Using carvedilol, or synergistic mixture thereof
06/05/2003US20030105100 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
06/05/2003US20030105099 Novel compounds and compositions as cathepsin inhibitors
06/05/2003US20030105092 Prevention of loss and restoration of bone mass by certain prostaglandin agonists
06/05/2003US20030105091 Omega-carboxy aryl substituted diphenyl ureas as p38 kinase inhibitors
06/05/2003US20030105079 Novel phenylalkyl diamine and amide analogs
06/05/2003US20030105072 Compounds, compositions, and methods for controlling biofilms
06/05/2003CA2837936A1 Peptidomimetic inhibitors of post-proline cleaving enzymes
06/05/2003CA2812024A1 Methods for ligand discovery
06/05/2003CA2468716A1 Heterocyclic amide compounds as apolipoprotein b inhibitors
06/05/2003CA2468422A1 3-biphenyl-substituted-3-substituted-4-ketolactam and ketolactone and their utilization as pesticide
06/05/2003CA2468192A1 Peptidomimetic inhibitors of post-proline cleaving enzymes
06/05/2003CA2464094A1 Methods for ligand discovery
06/04/2003EP1315699A2 Hydrazine-based and carbonyl-based bifunctional crosslinking reagents
06/04/2003EP1315698A1 Pyrrolidines as inhibitors of neuraminidases
06/04/2003EP1114027B1 The preparation of n-substituted-hydroxycycloalkylamine derivatives
06/04/2003EP0882032B1 Process for the preparation of gamma-butyrolactone and the use thereof
06/04/2003EP0656037B1 Metal-mediated cross-coupling with ring-metalated porphyrins
06/04/2003CN1422272A Pyrrolopyridazine compound
06/04/2003CN1422271A Pyrrolopyrimidinone derivatives, process of preparation and use
06/04/2003CN1422263A Estrogen agonist/antagonist metabolites
1 ... 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 ... 404